Genetic variation, Fcγ receptors, KIRs and infection: The evolution of autoimmunity

Current Opinion in Immunology

Volumn 22, Issue 6, 2010, Pages 715-722

  Espeli, Marion ^a,b   Niederer, Heather A ^a,b   Traherne, James A ^a,c   Trowsdale, John ^b,c   Smith, Kenneth G C ^a,b  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^c UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

FC RECEPTOR; FC RECEPTOR IIB; FC RECEPTOR IIIB; HLA A ANTIGEN; HLA B ANTIGEN; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR; LYMPHOCYTE RECEPTOR; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; UNCLASSIFIED DRUG;

ALLELE; AUTOIMMUNE DISEASE; AUTOIMMUNITY; BINDING AFFINITY; COPY NUMBER VARIATION; DISEASE COURSE; FCGR2A GENE; FCGR2B GENE; FCGR2C GENE; FCGR3B GENE; GENE; GENE LOCUS; GENETIC ASSOCIATION; GENETIC CONSERVATION; GENETIC PREDISPOSITION; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; HAPLOTYPE; HUMAN; IMMUNE RESPONSE; IMMUNOMODULATION; IMMUNOPATHOGENESIS; IMMUNOREGULATION; INFECTION; INFECTION PREVENTION; INFECTION SENSITIVITY; KIR GENE; MALARIA; MOLECULAR EVOLUTION; NONHUMAN; POINT MUTATION; PROTEIN FAMILY; PROTEIN FUNCTION; RECEPTOR BINDING; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM; SYSTEMIC LUPUS ERYTHEMATOSUS; VIRUS INFECTION;

AUTOIMMUNITY; GENETIC VARIATION; HUMANS; INFECTION; RECEPTORS, IGG; RECEPTORS, KIR;

EID: 78649879413     PISSN: 09527915     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.coi.2010.10.003     Document Type: Review

References (81)

1. Nei M., Rooney A.P. Concerted and birth-and-death evolution of multigene families. Annu Rev Genet 2005, 39:121-152.
2. Willcocks L.C., Smith K.G.C., Clatworthy M.R. Low-affinity Fcgamma receptors, autoimmunity and infection. Expert Rev Mol Med 2009, 11:e24.
3. Warmerdam P.A., Nabben N.M., van de Graaf S.A., van de Winkel J.G., Capel P.J. The human low affinity immunoglobulin G Fc receptor IIC gene is a result of an unequal crossover event. J Biol Chem 1993, 268:7346-7349.
4. Qiu W.Q., de Bruin D., Brownstein B.H., Pearse R., Ravetch J.V. Organization of the human and mouse low-affinity Fc gamma R genes: duplication and recombination. Science 1990, 248:732-735.
5. McCarroll S.A., Kuruvilla F.G., Korn J.M., Cawley S., Nemesh J., Wysoker A., Shapero M.H., de Bakker P.I., Maller J.B., Kirby A., et al. Integrated detection and population-genetic analysis of SNPs and copy number variation. Nat Genet 2008, 40:1166-1174.
6. Redon R., Ishikawa S., Fitch K.R., Feuk L., Perry G.H., Andrews T.D., Fiegler H., Shapero M.H., Carson A.R., Chen W., et al. Global variation in copy number in the human genome. Nature 2006, 444:444-454.
7. Willcocks L.C., Lyons P.A., Clatworthy M.R., Robinson J.I., Yang W., Newland S.A., Plagnol V., McGovern N.N., Condliffe A.M., Chilvers E.R., et al. Copy number of FCGR3B, which is associated with systemic lupus erythematosus, correlates with protein expression and immune complex uptake. J Exp Med 2008, 205:1573-1582.
8. Niederer H.A., Willcocks L.C., Rayner T.F., Yang W., Lau Y.L., Williams T.N., Scott J.A., Urban B.C., Peshu N., Dunstan S.J., et al. Copy number, linkage disequilibrium and disease association in the FCGR locus. Hum Mol Genet 2010, 19:3282-3294.
9. Brown E.E., Edberg J.C., Kimberly R.P. Fc receptor genes and the systemic lupus erythematosus diathesis. Autoimmunity 2007, 40:567-581.
10. Smith K.G.C., Clatworthy M.R. FcgammaRIIB in autoimmunity and infection: evolutionary and therapeutic implications. Nat Rev Immunol 2010, 10:328-343.
11. Nimmerjahn F., Ravetch J.V. Fcgamma receptors as regulators of immune responses. Nat Rev Immunol 2008, 8:34-47.
12. Takai T., Ono M., Hikida M., Ohmori H., Ravetch J.V. Augmented humoral and anaphylactic responses in Fc gamma RII-deficient mice. Nature 1996, 379:346-349.
13. Clatworthy M.R., Smith K.G.C. FcgammaRIIb balances efficient pathogen clearance and the cytokine-mediated consequences of sepsis. J Exp Med 2004, 199:717-723.
14. Gjertsson I., Kleinau S., Tarkowski A. The impact of Fcgamma receptors on Staphylococcus aureus infection. Microb Pathog 2002, 33:145-152.
15. Clatworthy M.R., Willcocks L., Urban B., Langhorne J., Williams T.N., Peshu N., Watkins N.A., Floto R.A., Smith K.G.C. Systemic lupus erythematosus-associated defects in the inhibitory receptor FcgammaRIIb reduce susceptibility to malaria. Proc Natl Acad Sci USA 2007, 104:7169-7174.
16. Brownlie R.J., Lawlor K.E., Niederer H.A., Cutler A.J., Xiang Z., Clatworthy M.R., Floto R.A., Greaves D.R., Lyons P.A., Smith K.G.C. Distinct cell-specific control of autoimmunity and infection by FcgammaRIIb. J Exp Med 2008, 205:883-895.
17. Pritchard N.R., Cutler A.J., Uribe S., Chadban S.J., Morley B.J., Smith K.G.C. Autoimmune-prone mice share a promoter haplotype associated with reduced expression and function of the Fc receptor FcgammaRII. Curr Biol 2000, 10:227-230.
18. Jiang Y., Hirose S., Abe M., Sanokawa-Akakura R., Ohtsuji M., Mi X., Li N., Xiu Y., Zhang D., Shirai J., et al. Polymorphisms in IgG Fc receptor IIB regulatory regions associated with autoimmune susceptibility. Immunogenetics 2000, 51:429-435.
19. Rahman Z.S., Niu H., Perry D., Wakeland E., Manser T., Morel L. Expression of the autoimmune Fcgr2b NZW allele fails to be upregulated in germinal center B cells and is associated with increased IgG production. Genes Immun 2007, 8:604-612.
20. Blank M.C., Stefanescu R.N., Masuda E., Marti F., King P.D., Redecha P.B., Wurzburger R.J., Peterson M.G., Tanaka S., Pricop L. Decreased transcription of the human FCGR2B gene mediated by the -343 G/C promoter polymorphism and association with systemic lupus erythematosus. Hum Genet 2005, 117:220-227.
21. Su K., Wu J., Edberg J.C., Li X., Ferguson P., Cooper G.S., Langefeld C.D., Kimberly R.P. A promoter haplotype of the immunoreceptor tyrosine-based inhibitory motif-bearing FcgammaRIIb alters receptor expression and associates with autoimmunity. I. Regulatory FCGR2B polymorphisms and their association with systemic lupus erythematosus. J Immunol 2004, 172:7186-7191.
22. Floto R.A., Clatworthy M.R., Heilbronn K.R., Rosner D.R., MacAry P.A., Rankin A., Lehner P.J., Ouwehand W.H., Allen J.M., Watkins N.A., et al. Loss of function of a lupus-associated FcgammaRIIb polymorphism through exclusion from lipid rafts. Nat Med 2005, 11:1056-1058.
23. Li X., Wu J., Carter R.H., Edberg J.C., Su K., Cooper G.S., Kimberly R.P. A novel polymorphism in the Fcgamma receptor IIB (CD32B) transmembrane region alters receptor signaling. Arthritis Rheum 2003, 48:3242-3252.
24. Kyogoku C., Dijstelbloem H.M., Tsuchiya N., Hatta Y., Kato H., Yamaguchi A., Fukazawa T., Jansen M.D., Hashimoto H., van de Winkel J.G., et al. Fcgamma receptor gene polymorphisms in Japanese patients with systemic lupus erythematosus: contribution of FCGR2B to genetic susceptibility. Arthritis Rheum 2002, 46:1242-1254.
25. Chu Z.T., Tsuchiya N., Kyogoku C., Ohashi J., Qian Y.P., Xu S.B., Mao C.Z., Chu J.Y., Tokunaga K. Association of Fcgamma receptor IIb polymorphism with susceptibility to systemic lupus erythematosus in Chinese: a common susceptibility gene in the Asian populations. Tissue Antigens 2004, 63:21-27.
26. Siriboonrit U., Tsuchiya N., Sirikong M., Kyogoku C., Bejrachandra S., Suthipinittharm P., Luangtrakool K., Srinak D., Thongpradit R., Fujiwara K., et al. Association of Fcgamma receptor IIb and IIIb polymorphisms with susceptibility to systemic lupus erythematosus in Thais. Tissue Antigens 2003, 61:374-383.
27. Willcocks L.C., Carr E.J., Niederer H.A., Rayner T.F., Williams T.N., Yang W., Scott J.A., Urban B.C., Peshu N., Vyse T.J., et al. A defunctioning polymorphism in FCGR2B is associated with protection against malaria but susceptibility to systemic lupus erythematosus. Proc Natl Acad Sci USA 2010, 107:7881-7885.
28. Williams T.N., Wambua S., Uyoga S., Macharia A., Mwacharo J.K., Newton C.R., Maitland K. Both heterozygous and homozygous alpha+ thalassemias protect against severe and fatal Plasmodium falciparum malaria on the coast of Kenya. Blood 2005, 106:368-371.
29. Kwiatkowski D.P. How malaria has affected the human genome and what human genetics can teach us about malaria. Am J Hum Genet 2005, 77:171-192.
30. Kotzin B.L. Systemic lupus erythematosus. Cell 1996, 85:303-306.
31. Greenwood B.M. Autoimmune disease and parasitic infections in Nigerians. Lancet 1968, 2:380-382.
32. Greenwood B.M., Herrick E.M., Voller A. Can parasitic infection suppress autoimmune disease?. Proc R Soc Med 1970, 63:19-20.
33. Butcher G. Autoimmunity and malaria. Trends Parasitol 2008, 24:291-292.
34. Kato M., Kawaguchi T., Ishikawa S., Umeda T., Nakamichi R., Shapero M.H., Jones K.W., Nakamura Y., Aburatani H., Tsunoda T. Population-genetic nature of copy number variations in the human genome. Hum Mol Genet 2010, 19:761-773.
35. Breunis W.B., van Mirre E., Geissler J., Laddach N., Wolbink G., van der Schoot E., de Haas M., de Boer M., Roos D., Kuijpers T.W. Copy number variation at the FCGR locus includes FCGR3A, FCGR2C and FCGR3B but not FCGR2A and FCGR2B. Hum Mutat 2009, 30:E640-E650.
36. Hollox E.J., Detering J.C., Dehnugara T. An integrated approach for measuring copy number variation at the FCGR3 (CD16) locus. Hum Mutat 2009, 30:477-484.
37. Aitman T.J., Dong R., Vyse T.J., Norsworthy P.J., Johnson M.D., Smith J., Mangion J., Roberton-Lowe C., Marshall A.J., Petretto E., et al. Copy number polymorphism in Fcgr3 predisposes to glomerulonephritis in rats and humans. Nature 2006, 439:851-855.
38. Fanciulli M., Norsworthy P.J., Petretto E., Dong R., Harper L., Kamesh L., Heward J.M., Gough S.C., de Smith A., Blakemore A.I., et al. FCGR3B copy number variation is associated with susceptibility to systemic, but not organ-specific, autoimmunity. Nat Genet 2007, 39:721-723.
39. Mamtani M., Anaya J.M., He W., Ahuja S.K. Association of copy number variation in the FCGR3B gene with risk of autoimmune diseases. Genes Immun 2010, 11:155-160.
40. Morris D.L., Roberts A.L., Witherden A.S., Tarzi R., Barros P., Whittaker J.C., Cook T.H., Aitman T.J., Vyse T.J. Evidence for both copy number and allelic (NA1/NA2) risk at the FCGR3B locus in systemic lupus erythematosus. Eur J Hum Genet 2010, 9:1027-1031.
41. McKinney C., Fanciulli M., Merriman M.E., Phipps-Green A., Alizadeh B.Z., Koeleman B.P., Dalbeth N., Gow P.J., Harrison A.A., Highton J., et al. Association of variation in Fc{gamma} receptor 3B gene copy number with rheumatoid arthritis in Caucasian samples. Ann Rheum Dis 2010, 9:1711-1716.
42. Salmon J.E., Edberg J.C., Brogle N.L., Kimberly R.P. Allelic polymorphisms of human Fc gamma receptor IIA and Fc gamma receptor IIIB. Independent mechanisms for differences in human phagocyte function. J Clin Invest 1992, 89:1274-1281.
43. Niederer H.A., Clatworthy M.R., Willcocks L.C., Smith K.G.C. FcgammaRIIB, FcgammaRIIIB, and systemic lupus erythematosus. Ann N Y Acad Sci 2010, 1183:69-88.
44. Davies K.A., Peters A.M., Beynon H.L., Walport M.J. Immune complex processing in patients with systemic lupus erythematosus. In vivo imaging and clearance studies. J Clin Invest 1992, 90:2075-2083.
45. Davies K.A., Robson M.G., Peters A.M., Norsworthy P., Nash J.T., Walport M.J. Defective Fc-dependent processing of immune complexes in patients with systemic lupus erythematosus. Arthritis Rheum 2002, 46:1028-1038.
46. Traherne J.A. Human MHC architecture and evolution: implications for disease association studies. Int J Immunogenet 2008, 35:179-192.
47. Gendzekhadze K., Norman P.J., Abi-Rached L., Graef T., Moesta A.K., Layrisse Z., Parham P. Co-evolution of KIR2DL3 with HLA-C in a human population retaining minimal essential diversity of KIR and HLA class I ligands. Proc Natl Acad Sci USA 2009, 106:18692-18697.
48. Guethlein L.A., Older Aguilar A.M., Abi-Rached L., Parham P. Evolution of killer cell Ig-like receptor (KIR) genes: definition of an orangutan KIR haplotype reveals expansion of lineage III KIR associated with the emergence of MHC-C. J Immunol 2007, 179:491-504.
49. Abi-Rached L., Kuhl H., Roos C., ten Hallers B., Zhu B., Carbone L., de Jong P.J., Mootnick A.R., Knaust F., Reinhardt R., et al. A small, variable, and irregular killer cell Ig-like receptor locus accompanies the absence of MHC-C and MHC-G in gibbons. J Immunol 2010, 184:1379-1391.
50. Single R.M., Martin M.P., Gao X., Meyer D., Yeager M., Kidd J.R., Kidd K.K., Carrington M. Global diversity and evidence for coevolution of KIR and HLA. Nat Genet 2007, 39:1114-1119.
51. Cao W., Bover L. Signaling and ligand interaction of ILT7: receptor-mediated regulatory mechanisms for plasmacytoid dendritic cells. Immunol Rev 2010, 234:163-176.
52. Cao W., Bover L., Cho M., Wen X., Hanabuchi S., Bao M., Rosen D.B., Wang Y.H., Shaw J.L., Du Q., et al. Regulation of TLR7/9 responses in plasmacytoid dendritic cells by BST2 and ILT7 receptor interaction. J Exp Med 2009, 206:1603-1614.
53. Lanier L.L. NK cell recognition. Annu Rev Immunol 2005, 23:225-274.
54. Vivier E., Tomasello E., Baratin M., Walzer T., Ugolini S. Functions of natural killer cells. Nat Immunol 2008, 9:503-510.
55. Fadda L., Borhis G., Ahmed P., Cheent K., Pageon S.V., Cazaly A., Stathopoulos S., Middleton D., Mulder A., Claas F.H., et al. Peptide antagonism as a mechanism for NK cell activation. Proc Natl Acad Sci USA 2010, 107:10160-10165.
56. van Bergen J., Thompson A., Retiere C., Trowsdale J., Koning F. Cutting edge: killer Ig-like receptors mediate " missing self" recognition in vivo. J Immunol 2009, 182:2569-2572.
57. Barrow A.D., Trowsdale J. The extended human leukocyte receptor complex: diverse ways of modulating immune responses. Immunol Rev 2008, 224:98-123.
58. Joncker N.T., Fernandez N.C., Treiner E., Vivier E., Raulet D.H. NK cell responsiveness is tuned commensurate with the number of inhibitory receptors for self-MHC class I: the rheostat model. J Immunol 2009, 182:4572-4580.
59. Norman P.J., Abi-Rached L., Gendzekhadze K., Korbel D., Gleimer M., Rowley D., Bruno D., Carrington C.V., Chandanayingyong D., Chang Y.H., et al. Unusual selection on the KIR3DL1/S1 natural killer cell receptor in Africans. Nat Genet 2007, 39:1092-1099.
60. Graef T., Moesta A.K., Norman P.J., Abi-Rached L., Vago L., Older Aguilar A.M., Gleimer M., Hammond J.A., Guethlein L.A., Bushnell D.A., et al. KIR2DS4 is a product of gene conversion with KIR3DL2 that introduced specificity for HLA-A*11 while diminishing avidity for HLA-C. J Exp Med 2009, 206:2557-2572.
61. Norman P.J., Abi-Rached L., Gendzekhadze K., Hammond J.A., Moesta A.K., Sharma D., Graef T., McQueen K.L., Guethlein L.A., Carrington C.V., et al. Meiotic recombination generates rich diversity in NK cell receptor genes, alleles, and haplotypes. Genome Res 2009, 19:757-769.
62. Traherne J.A., Martin M., Ward R., Ohashi M., Pellett F., Gladman D., Middleton D., Carrington M., Trowsdale J. Mechanisms of copy number variation and hybrid gene formation in the KIR immune gene complex. Hum Mol Genet 2010, 19:737-751.
63. Ordonez D., Meenagh A., Gomez-Lozano N., Castano J., Middleton D., Vilches C. Duplication, mutation and recombination of the human orphan gene KIR2DS3 contribute to the diversity of KIR haplotypes. Genes Immun 2008, 9:431-437.
64. Martin M.P., Single R.M., Wilson M.J., Trowsdale J., Carrington M. KIR haplotypes defined by segregation analysis in 59 Centre d'Etude Polymorphisme Humain (CEPH) families. Immunogenetics 2008, 60:767-774.
65. Hsu K.C., Chida S., Geraghty D.E., Dupont B. The killer cell immunoglobulin-like receptor (KIR) genomic region: gene-order, haplotypes and allelic polymorphism. Immunol Rev 2002, 190:40-52.
66. Raulet D.H., Vance R.E. Self-tolerance of natural killer cells. Nat Rev Immunol 2006, 6:520-531.
67. Anfossi N., Andre P., Guia S., Falk C.S., Roetynck S., Stewart C.A., Breso V., Frassati C., Reviron D., Middleton D., et al. Human NK cell education by inhibitory receptors for MHC class I. Immunity 2006, 25:331-342.
68. Thomas R., Yamada E., Alter G., Martin M.P., Bashirova A.A., Norman P.J., Altfeld M., Parham P., Anderson S.K., McVicar D.W., et al. Novel KIR3DL1 alleles and their expression levels on NK cells: convergent evolution of KIR3DL1 phenotype variation?. J Immunol 2008, 180:6743-6750.
69. Thananchai H., Gillespie G., Martin M.P., Bashirova A., Yawata N., Yawata M., Easterbrook P., McVicar D.W., Maenaka K., Parham P., et al. Cutting edge: allele-specific and peptide-dependent interactions between KIR3DL1 and HLA-A and HLA-B. J Immunol 2007, 178:33-37.
70. Sharma D., Bastard K., Guethlein L.A., Norman P.J., Yawata N., Yawata M., Pando M., Thananchai H., Dong T., Rowland-Jones S., et al. Dimorphic motifs in D0 and D1+D2 domains of killer cell Ig-like receptor 3DL1 combine to form receptors with high, moderate, and no avidity for the complex of a peptide derived from HIV and HLA-A*2402. J Immunol 2009, 183:4569-4582.
71. Martin M.P., Qi Y., Gao X., Yamada E., Martin J.N., Pereyra F., Colombo S., Brown E.E., Shupert W.L., Phair J., et al. Innate partnership of HLA-B and KIR3DL1 subtypes against HIV-1. Nat Genet 2007, 39:733-740.
72. Hiby S.E., Walker J.J., O'Shaughnessy K.M., Redman C.W., Carrington M., Trowsdale J., Moffett A. Combinations of maternal KIR and fetal HLA-C genes influence the risk of preeclampsia and reproductive success. J Exp Med 2004, 200:957-965.
73. Li H., Pascal V., Martin M.P., Carrington M., Anderson S.K. Genetic control of variegated KIR gene expression: polymorphisms of the bi-directional KIR3DL1 promoter are associated with distinct frequencies of gene expression. PLoS Genet 2008, 4:e1000254.
74. Yawata M., Yawata N., Draghi M., Little A.M., Partheniou F., Parham P. Roles for HLA and KIR polymorphisms in natural killer cell repertoire selection and modulation of effector function. J Exp Med 2006, 203:633-645.
75. Khakoo S.I., Thio C.L., Martin M.P., Brooks C.R., Gao X., Astemborski J., Cheng J., Goedert J.J., Vlahov D., Hilgartner M., et al. HLA and NK cell inhibitory receptor genes in resolving hepatitis C virus infection. Science 2004, 305:872-874.
76. Nelson G.W., Martin M.P., Gladman D., Wade J., Trowsdale J., Carrington M. Cutting edge: heterozygote advantage in autoimmune disease: hierarchy of protection/susceptibility conferred by HLA and killer Ig-like receptor combinations in psoriatic arthritis. J Immunol 2004, 173:4273-4276.
77. Momot T., Koch S., Hunzelmann N., Krieg T., Ulbricht K., Schmidt R.E., Witte T. Association of killer cell immunoglobulin-like receptors with scleroderma. Arthritis Rheum 2004, 50:1561-1565.
78. Lowe D.P., Cook M.A., Bowman S.J., Briggs D.C. Association of killer cell immunoglobulin-like receptors with primary Sjogren's syndrome. Rheumatology (Oxford) 2009, 48:359-362.
79. Parham P. The genetic and evolutionary balances in human NK cell receptor diversity. Semin Immunol 2008, 20:311-316.
80. Abi-Rached L., Parham P. Natural selection drives recurrent formation of activating killer cell immunoglobulin-like receptor and Ly49 from inhibitory homologues. J Exp Med 2005, 201:1319-1332.
81. Bruhns P., Iannascoli B., England P., Mancardi D.A., Fernandez N., Jorieux S., Daeron M. Specificity and affinity of human Fcgamma receptors and their polymorphic variants for human IgG subclasses. Blood 2009, 113:3716-3725.